Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
An Interview With Kim Boericke
Veristat’s new CEO, Kim McLean Boericke, is one step closer to changing the tide in representing the small fraction of companies led by women and is now the only female with the highest job among the top-8 clinical research organizations (CROs). read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Arcturus, Thermo Fisher Partner on Phase 3 Manufacturing for Cystic Fibrosis mRNA Therapy
Thursday, July 02, 2026
Arcturus Therapeutics has entered a strategic collaboration with Thermo Fisher Scientific to support late-stage development and potential ... read more
Lonza Acquires TfR1 Blood-Brain Barrier Technology from Nona, Expands Collaboration
Thursday, July 02, 2026
Lonza has acquired rights to Nona Biosciences’ transferrin receptor (TfR1)-based blood-brain barrier (BBB) technology and expanded its existing ... read more
UC Irvine, GlyTR Advance AAV-Based CAR-T Program with ProBio Manufacturing Support
Thursday, July 02, 2026
The University of California, Irvine (UC Irvine) and GlyTR Therapeutics are advancing a preclinical CAR-T program targeting solid tumors, supported by... read more
Halozyme Appoints David Ramsay as President Drug Delivery
Wednesday, July 01, 2026
Halozyme Therapeutics announced the appointment of David Ramsay as President Drug Delivery, effective June 30, 2026. read more
Rezon Bio Appoints Chief Business Officer to Accelerate Global Commercial Expansion
Wednesday, July 01, 2026
Rezon Bio announced the appointment of Dr. Hubert Scholze as Chief Business Officer (CBO), effective July 1, 2026. read more